Background illustration for clinical trials search

Paid Clinical Trials Fayetteville

Discover 159 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for
Solid Tumors (Phase 1)
Location: Springdale AR, Houston TX, New Haven CT
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT07362888

Phase1, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: Springdale AR, Brampton, Toronto, Fairfax VA,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

for
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer,
Location: Springdale AR
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT05415098

Phase1, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Springdale AR, Dallas TX, Denver CO, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase2, Recruiting

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Springdale AR, Kansas City MO, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Springdale AR, St Louis MO, Fort Worth TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Springdale AR, Fairway KS, Germantown TN, Dallas TX,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase1, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In

for
NSCLC Stage IV
Location: Springdale AR, St Louis MO, Nashville TN, Cincinnati OH,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Springdale AR, Springfield MO, Westwood KS, Memphis TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Springdale AR, Merriam KS, Wichita KS, Denison TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase2, Phase3, Recruiting

Family Model DSME in FBOs in the RMI

for
Diabetes Mellitus, Type 2
Location: Springdale AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT05502016

Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Springdale AR, Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 1 - 23

Code: NCT07422337

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Springdale AR, Tulsa OK, Edmond OK, Lenexa KS,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase3, Recruiting

Delivering HOPE (Helping Women Optimize Prenatal Equity)

for
Gestational Weight Gain, Diet, Healthy,
Location: Springdale AR, Lavaca AR, Marshall AR, Corning AR,
Sponsor: University of Arkansas

Sex: Female

Age: 16 - 44

Code: NCT06814509

Recruiting

ALTO-100 in Bipolar Disorder With Depression (BD-D)

for
Bipolar Disorder I or II With a Major Depressive Episode
Location: Fayetteville AR, Little Rock AR, Lincoln NE, Houston TX,
Sponsor: Alto Neuroscience

Sex: All

Age: 18 - 70

Code: NCT06656416

Phase2, Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

for
Schizophrenia
Location: Rogers AR, Richardson TX, Saint Charles MO, St Louis MO,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06961968

Phase3, Recruiting

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: Rogers AR, Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07123103

Phase1, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Springdale AR, Kansas City MO, Shreveport LA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

for
Major Depressive Disorder
Location: Rogers AR, Little Rock AR, Oklahoma City OK, Memphis TN,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT06775379

Phase3, Recruiting

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Rogers AR, Little Rock AR, Oklahoma City OK, Dallas TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18+

Code: NCT06701903

Phase2, Recruiting